Overview

  • Product nameSD 169
  • Description
    Potent, selective and ATP-competitive p38α MAPK inhibitor
  • Biological descriptionPotent, selective and ATP-competitive p38α MAPK inhibitor (IC50 values are 3.2 and 122 nM for α and β, respectively). Orally active. Promotes axonal regeneration in vivo.
  • Purity> 99%

Properties

    References for SD 169 (ab120836)

    This product has been referenced in:
    • Medicherla S  et al. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes. J Pharmacol Exp Ther 318:99-107 (2006). Read more (PubMed: 16603672) »
    • Myers RR  et al. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 184:606-14 (2003). Read more (PubMed: 14769353) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120836.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"